ELISA/assay

Coronavirus COVID-19 IgM ELISA Assay

KTR-1033

1 x 96 well

865 USD

Coronavirus COVID-19 IgM ELISA Assay

This ELISA kit is designed, developed, and produced for the qualitative measurement of the COVID-19 IgM antibody in serum. This assay utilizes the “IgM capture” method on microplate based enzyme immunoassay technique. Assay controls and samples are added to the microtiter wells of a microplate that was coated with an anti-human IgM specific antibody. After the first incubation period, the unbound protein matrix is removed with a subsequent washing step. A horseradish peroxidase (HRP) labeled recombinant COVID-19 antigen is added to each well. After an incubation period, an immunocomplex of "Anti-hIgM antibody - human COVID-19 IgM antibody - HRP labeled COVID-19 antigen" is formed if there is novel coronavirus IgM antibody present in the tested materials. The unbound tracer antigen is removed by the subsequent washing step. HRP-labeled COVID-19 antigen tracer bound to the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the tracer antigen bound to the coronavirus IgM on the wall of the microtiter well is proportional to the amount of the coronavirus IgM antibody level in the tested materials.

ELISA

Assay Kits

Immunology

1 x 96 well

COVID-19, Coronavirus

COVID-19, Coronavirus

Cut-off

10 µl

Serum

1.5 hours

Human

RUO

wet

2-8C

865 USD